7.93
+0.01
+(0.13%)
At close: January 30 at 4:00:01 PM EST
7.12
-0.81
(-10.21%)
Pre-Market: 4:04:21 AM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
255,075.00
223,935.00
160,030.00
22,104.00
Total Liabilities Net Minority Interest
29,227.00
28,352.00
7,715.00
2,741.00
Total Equity Gross Minority Interest
225,848.00
195,583.00
152,315.00
19,363.00
Total Capitalization
225,848.00
195,583.00
152,315.00
19,363.00
Preferred Stock Equity
--
--
--
128,076.00
Common Stock Equity
225,848.00
195,583.00
152,315.00
-108,713.00
Capital Lease Obligations
19,557.00
20,858.00
975.00
--
Net Tangible Assets
225,848.00
195,583.00
152,315.00
19,363.00
Working Capital
219,437.00
186,245.00
146,349.00
15,794.00
Invested Capital
225,848.00
195,583.00
152,315.00
-108,713.00
Tangible Book Value
225,848.00
195,583.00
152,315.00
-108,713.00
Total Debt
19,557.00
20,858.00
975.00
--
Share Issued
49,350.79
37,771.92
29,211.64
29,211.64
Ordinary Shares Number
49,350.79
37,771.92
29,211.64
29,211.64
12/31/2020 - 10/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRDA Entrada Therapeutics, Inc.
13.37
+0.83%
CGEM Cullinan Therapeutics, Inc.
10.98
-2.40%
TNGX Tango Therapeutics, Inc.
3.1100
0.00%
IMCR Immunocore Holdings plc
32.61
+3.07%
IMTX Immatics N.V.
5.40
+1.31%
MOLN Molecular Partners AG
5.23
+0.19%
MBX MBX Biosciences, Inc.
11.64
+13.34%
NAMS NewAmsterdam Pharma Company N.V.
21.77
+4.76%
REPL Replimune Group, Inc.
13.62
-3.20%
RCUS Arcus Biosciences, Inc.
13.38
+2.84%